Program

Executive Summary：
Dr. Sheng-Han Huang, MD, FIPP, is a board-certified neurosurgeon and Lecturer at the Department of Neurosurgery, Linkou Chang Gung Memorial Hospital, Taiwan. With dual expertise in minimally invasive spine surgery and neuromodulation, he brings a unique perspective to the management of complex pain conditions. Dr. Huang is a Fellow of Interventional Pain Practice (FIPP), certified by the World Institute of Pain, and currently pursuing his Ph.D. in biomedical electronics and bioinformatics at National Taiwan University. His research focuses on advancing non-invasive neuromodulation technologies, particularly the use of focused ultrasound (FUS) in treating spinal neuropathic pain. An active contributor to both clinical innovation and academic research, he has received multiple national awards and presented his work internationally. Dr. Huang is dedicated to bridging cutting-edge technology and clinical neuroscience to improve quality of life for patients suffering from chronic pain.

Lecture Abstract：
Title: From Molecules to Waves: Evolving Strategies in Spinal Pain Neuromodulation
Neuropathic pain is a debilitating condition that significantly impacts patients’ quality of life and remains a major therapeutic challenge due to its complex and often refractory nature. Traditional pharmacologic approaches offer limited relief, prompting the rise of neuromodulation as a targeted and promising intervention. Techniques such as pulsed radiofrequency (PRF), spinal cord stimulation (SCS), and peripheral nerve stimulation (PNS) have shown substantial benefits by modulating pain circuits without the need for destructive procedures. More recently, focused ultrasound (FUS) has emerged as a groundbreaking non-invasive neuromodulation platform, enabling precise and reversible modulation of deep neural structures with millimeter accuracy. This lecture will provide a comprehensive overview of the current and evolving strategies in spinal pain neuromodulation, delving into the mechanisms, clinical applications, and translational research surrounding these technologies. Special focus will be placed on the integration of bioelectronic and acoustic modalities in the treatment of spinal neuropathic pain, bridging molecular mechanisms with energy-based therapeutic innovation.